Laparoscopic sleeve gastrectomy on heart transplant recipient with body mass index of 34 kg/m2 and metabolic syndrome

Bariatric surgery has demonstrated great benefits for patients with severe obesity in terms of better control of co-morbidities and an improved quality of life [1]. Sleeve gastrectomy has been used for high-risk patients, given its effect on weight loss, with a lower risk than gastric bypass [2,3]. In some patients, a body mass index (BMI) of 35 kg/m 2 can be associated with significant co-morbidities. These patients could benefit from bariatric surgery.